Oramed Pharmaceuticals Inc. (ORMP)
Market Closed
30 Jul, 20:00
$
4. 12
+0.15
+3.7783%
$
168.62M Market Cap
16.21 P/E Ratio
- Div Yield
149,036 Volume
-0.31 Eps
$ 3.97
Previous Close Want to track ORMP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Oramed Pharmaceuticals Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Point72 Asset Management LP Point72 Asset Management LP | 26,052 | $74,584 | $106,813.2 | $32,229.2 | 43.21% |
 Rekah Franca Catalyst Funds Management Pty Ltd. | 23,500 | $79,900 | $96,467.5 | $16,567.5 | 20.74% |
 Taro Kuriyama Axq Capita LLP | 11,326 | $38,508 | $46,436.6 | $7,928.6 | 20.59% |
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 2 | $7 | $8.2 | $1.2 | 17.14% |
| AAL Avraham A. Levitan Glass Jacobson Investment Advisors LLC | 19,890 | $123,834.64 | $80,156.7 | -$43,677.94 | -35.27% |
| LCB Lawrence C. Busch Sage Capital Management, LLC | 17,977 | $53,082.02 | $72,447.31 | $19,365.29 | 36.48% |
